Quantamerix is developing a low-cost diagnostic for newborn screening of diseases, particularly inherited metabolic disorders. Their focus is on low-resource settings in China that cannot sustain the specialized infrastructure or administrative burden for traditional screening. The technology is disposable, inexpensive, and reader-less, and as easy to use as a thermometer. In February 2012, Quantamerix placed 2nd in Life Sciences track of MIT $100K ACCELERATE Competition. They also received the MIT IDEAS Global Challenge Grant and advanced to the semifinal round of MIT $100K Business Plan Contest.